XML 49 R21.htm IDEA: XBRL DOCUMENT v3.22.4
IMPAIRMENT OF LONG-LIVED AND OTHER ASSETS
12 Months Ended
Dec. 31, 2022
Impairment or Disposal of Tangible Assets Disclosure [Abstract]  
IMPAIRMENT OF LONG-LIVED AND OTHER ASSETS
12.
IMPAIRMENT OF LONG-LIVED AND OTHER ASSETS

The Company reviews for impairment indicators related to its long-lived assets on a quarterly basis and goodwill on an annual basis or whenever events or changes in circumstances indicate the carrying amount of those assets may not be fully recoverable. The following table is a summary of the evaluations performed during 2022 by asset classification.

 

Asset

 

Impairment

 

Valuation

 

Valuation

 

Category

 

Test

 

Approach

 

Multiple

First and second quarters

 

 

 

 

 

 

 

Goodwill

 

Qualitative

 

N/A

 

N/A

 

Tradename intangible assets

 

Qualitative

 

N/A

 

N/A

 

Other long-lived assets

 

Qualitative

 

N/A

 

N/A

 

 

 

 

 

 

 

 

Third quarter

 

 

 

 

 

 

 

Goodwill

 

Qualitative

 

N/A

 

N/A

 

Tradename intangible assets

 

Qualitative

 

N/A

 

N/A

 

Other long-lived assets

 

Qualitative

 

Market

 

2.2 to 6 times

 

 

 

 

 

 

 

 

Fourth quarter

 

 

 

 

 

 

 

Goodwill

 

Quantitative

 

Market and Income

 

2.2 to 7 times

 

Tradename intangible assets

 

Quantitative

 

Income

 

N/A

 

Other long-lived assets

 

Quantitative

 

Market

 

2.2 to 6 times

See Note 1 for a discussion of the Company’s impairment policy and a description of qualitative and quantitative impairment assessments.

Below is a summary of impairment charges for the periods indicated:

 

 

Year Ended

 

 

December 31,

 

 

2020

 

2021

 

2022

U.S. segment

 

 

 

 

 

 

Theatre properties

 

$12.4

 

$6.4

 

$19.7

Theatre operating lease right-of-use assets

 

13.2

 

6.8

 

34.0

Investment in NCM (1)

 

92.7

 

 

113.2

Other

 

2.5

 

 

3.9

U.S. total

 

120.8

 

13.2

 

170.8

 

 

 

 

 

 

 

International segment

 

 

 

 

 

 

Theatre properties

 

10.0

 

4.0

 

2.2

Theatre operating lease right-of-use assets

 

5.0

 

3.2

 

1.1

Goodwill

 

16.1

 

 

Intangible assets, net

 

0.8

 

0.4

 

International total

 

31.9

 

7.6

 

3.3

 

 

 

 

 

 

 

Total impairment

 

$152.7

 

$20.8

 

$174.1

(1)
See discussion at Fair Value of NCM Investment in Note 9.

For the years ended December 31, 2020, 2021 and 2022, impairment charges were primarily due to the prolonged impact of the COVID-19 pandemic, as discussed in Note 3. Additionally, impairment charges recorded for the year ended December 31, 2022 reflected the recovery levels and the impact on estimated cash flows for specific assets.